Riskpilot← Back to searchSign inGet full accessViklinik Vårdcentral Lund AB
ABActiveOrg 5593184707Dalbyvägen 22General medical practice activities · NACE 8621Est. 202128 employees
Revenue 2025
SEK 41,8M
+29% vs 2024
EBITDA margin
9.2%
+662% vs 2024
Equity ratio
34.3%
Financial strength
Net profit 2025
SEK 3,2M
+2837% vs 2024
| Revenue | SEK 41,8M | +29% |
| EBITDA | SEK 3,8M | +662% |
| Net profit | SEK 3,2M | +2837% |
| Total assets | SEK 9,6M | +53% |
| Equity | SEK 3,3M | +2425% |
| Employees | 28 | — |
Legal name
Viklinik Vårdcentral Lund AB
Org number
5593184707
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
20 maj 2021
Share capital
SEK 25 000
Employees
28 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Företaget bedriver verksamhet inom hälso- och sjukvård, friskvård och därtill förenlig verksamhet.
Address
Dalbyvägen 22
Email
hej@viklinik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 1 750 | 21 577 | 32 499 | 41 776 |
| Staff expenses | — | −11 346 | −19 142 | — |
| EBITDA | −1 626 | −847 | 501 | 3 823 |
| Depreciation & amort. | −26 | −265 | −389 | −405 |
| EBIT | −1 652 | −1 113 | 112 | 3 418 |
| Net financials | −1 | −1 | −5 | −9 |
| Profit before tax | −1 339 | −1 428 | 107 | 3 304 |
| Tax | −0 | — | — | −148 |
| Net profit | −1 339 | −1 428 | 107 | 3 156 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 2 215 | 4 295 | 6 276 | 9 589 |
| Equity | 136 | 23 | 130 | 3 286 |
| Long-term debt | 0 | — | — | 0 |
| Short-term debt | 2 078 | 4 273 | 6 146 | 6 197 |
| Total debt | 2 078 | 4 273 | 6 146 | 6 197 |
EBITDA margin
9.2%
This company
15.8%
Market median
-42% vs market
20222025
Equity ratio
34.3%
This company
38.2%
Market median
+10% vs market
20222025
Return on equity
96.0%
This company
18.4%
Market median
+422% vs market
20222025
Net profit margin
7.6%
This company
8.1%
Market median
-6% vs market
20222025
Asset turnover
4.36×
This company
1.12×
Market median
+289% vs market
20222025
Debt / equity
1.92×
This company
0.62×
Market median
-210% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JM Chief Auditor | Chief Auditor | 2025 |
PM Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
KR Chief Auditor | Chief Auditor | 2025 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2021 | |
| Chairman | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 80% | 80% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
iKLINIK Sverige Holding AB
Viklinik Vårdcentral Lund AB Board members of Viklinik Vårdcentral Lund AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johanna Marie Edman | Chief Auditor | 0 companies |
| Per Marcus Nilsson Tervahauta | Chief Executive Officer | 0 companies |
| Kent Robert Axgart Wennerlund | Chief Auditor | 0 companies |
| Jonas Frederik Stellan Winge | Board of Directors | 0 companies |
| L Matilda C Nilsson Tervahauta | Deputy Board Member | 0 companies |
| Per Henrik Thomas Carlsson | Chairman | 0 companies |